Ethyl 4-formyl-1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazole-3-carboxylate

Catalog No. :
ACKRLV741
CAS No. :
2138085-66-0
Molecular Formula :
C12H16N2O4
Molecular Weight :
252.27

IUPAC Name:ethyl 4-formyl-1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazole-3-carboxylate

Ethyl 4-formyl-1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazole-3-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$312.00Login to see priceInquiryInquiry
100mg98%$458.00Login to see priceInquiryInquiry
250mg98%$647.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 4-formyl-1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazole-3-carboxylate
IUPAC Nameethyl 4-formyl-1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazole-3-carboxylate
Molecular FormulaC12H16N2O4
Molecular Weight252.27
SMILESO=C(C1=NN(C2CCOCC2)C=C1C=O)OCC
InChI KeyGNKZODNOKNXKSA-UHFFFAOYSA-N
Synonymethyl 4-formyl-1-(oxan-4-yl)-1H-pyrazole-3-carboxylate;Ethyl 4-formyl-1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazole-3-carboxylate;1H-Pyrazole-3-carboxylic acid, 4-formyl-1-(tetrahydro-2H-pyran-4-yl)-, ethyl ester
CAS No.2138085-66-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACKRLV741 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKRLV741 route product structure diagram
    ACKRLV7412138085-66-0
Inquiry

2. ACKRLV741 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCPBN784 route compound structure diagram
    ACCPBN784179692-09-2 In Stock
  2. Plus
  3. ACBLNQ064 route compound structure diagram
    ACBLNQ064134419-59-3 In Stock
  4. Then
  5. ACKRLV741 route product structure diagram
    ACKRLV7412138085-66-0
Inquiry

Comments (0)